B-crystallin regulation of angiogenesis by modulation of VEGF

The effect of proteasome inhibitor MG132 on experimental inflammatory bowel disease

(2009) S. Inoue et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

αB-crystallin suppresses oxidative stress-induced astrocyte apoptosis by inhibiting caspase-3 activation

(2009) Joo-Hyun Shin et al.   NEUROSCIENCE RESEARCH

MG-132 Inhibits Telomerase Activity, Induces Apoptosis and G1Arrest Associated with Upregulated p27kip1 Expression and Downregulated Survivin Expression in Gastric Carcinoma Cells

(2008) Weiguo Zhang et al.   CANCER INVESTIGATION

MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: involvement of nuclear factor-κB and activator protein-1

(2008) Pablo C. Ortiz-Lazareno et al.   IMMUNOLOGY

One step at a time: endoplasmic reticulum-associated degradation

(2008) Shruthi S. Vembar et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy

(2008) Esther J. Kuiper et al.   PLoS One

Vascular endothelial growth factor in eye disease

(2008) J.S. Penn et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Exacerbation of retinal degeneration in the absence of alpha crystallins in an in vivo model of chemically induced hypoxia

(2007) Jennifer Yaung et al.   EXPERIMENTAL EYE RESEARCH

βA3/A1-crystallin in astroglial cells regulates retinal vascular remodeling during development

(2007) Debasish Sinha et al.   MOLECULAR AND CELLULAR NEUROSCIENCE